Alaunos Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Alaunos Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 100% to $5,000. The net income raised on -$35,140,000 and profit margin reached -702800%. Total operating expenses were $29,469,000.
Profit Margin
| 2014 | 1.37M | -31.78M | -2314.71% |
|---|---|---|---|
| 2015 | 4.33M | -120.08M | -2772.11% |
| 2016 | 6.86M | -165.29M | -2409.23% |
| 2017 | 6.38M | -54.32M | -850.26% |
| 2018 | 146K | -53.11M | -36381.51% |
| 2019 | 0 | -177.91M | |
| 2020 | 0 | -78.84M | |
| 2021 | 398K | -76.89M | -19320.1% |
| 2022 | 2.92M | -37.59M | -1286.69% |
| 2023 | 5K | -35.14M | -702800% |
TCRT Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 5K | 2.92M | 398K | 0 | 0 | 146K | 6.38M | 6.86M | 4.33M | 1.37M |
Cost of revenue | 4.80M | 2.75M | 740K | 1.12M | 629K | 0 | 0 | 0 | 0 | 0 |
Gross profit | -4.79M | 163K | -342K | -1.12M | -629K | 146K | 6.38M | 6.86M | 4.33M | 1.37M |
Operating exp. | ||||||||||
Research and development | 16.27M | 25.01M | 49.64M | 52.69M | 38.33M | 34.13M | 45.08M | 157.79M | 106.78M | 32.70M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 29.46M | 38.16M | 77.20M | 80.36M | 57.85M | 54.05M | 59.88M | 172.16M | 124.43M | 44.87M |
Operating income | -34.26M | -35.10M | -77.54M | -80.36M | 2.26M | -53.90M | -53.49M | -165.30M | -120.1M | -43.49M |
Other income (expenses), net | -873K | -2.62M | -1.20M | 385K | -120.06M | 789K | -830K | 10K | 12K | 11.71M |
Income before tax | -35.14M | -37.73M | -78.75M | -79.97M | -117.79M | -53.11M | -54.32M | -165.29M | -120.08M | -31.78M |
Income tax expense | 0 | -133K | -1.85M | -1.12M | 60.12M | -947K | 2.12M | 114K | -12K | -23.44M |
Net income | -35.14M | -37.59M | -76.89M | -78.84M | -177.91M | -53.11M | -54.32M | -165.29M | -120.08M | -31.78M |
Earnings per share | ||||||||||
Basic EPS | -21.97 | -2.6 | -5.38 | -56.42 | -15.89 | -0.37 | -59.5 | -1.27 | -143.63 | -47.14 |
Diluted EPS | -21.97 | -2.6 | -5.38 | -56.42 | -15.89 | -0.37 | -59.5 | -1.27 | -143.63 | -47.14 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |